-
My first question was regarding the EBITDA margin, as it has been like from the last 4-5 quarters, it has been not major growth has been there in the margin. In the last quarter, it has been 11.6%. What do you expect specifically with which segment or like in which way it will be growing margin?
Read in transcript -
I am saying that the products which are innovated in the last 2 -3 years, how much they are contributing to total revenue?
Read in transcript
Analyst questions
Divyansh Jaju
Trinetra Asset Managers
2Calls
2Companies
ROSSARI
All company callsRossari Biotech Limited
FY2027 Q1
20 Jul 2026
KALAMANDIR
All company callsSai Silks (Kalamandir) Limited
Sai Silks (Kalamandir) Limited
16 Jul 2026
-
So my question was, what's the state-wise and the format -wise split will be of the 1,00,000 square feet expansion target, which is there for FY 27? And apart from this, is there any new state entry outside South India or we will be doing expansion more in the same only?
Read in transcript -
Okay. And the guidance you have given in the previous quarter for the revenue growth and the EBITDA margin will remain same only for next FY27?
Read in transcript -
So my question was, what's the state-wise and the format -wise split will be of the 1,00,000 square feet expansion target, which is there for FY 27? And apart from this, is there any new state entry outside South India or we will be doing expansion more in the same only?
Read in transcript